QDL — Integrated Continuous Glucose Monitoring System For Professional Retrospective Use Class II

FDA Device Classification

Classification Details

Product Code
QDL
Device Class
Class II
Regulation Number
862.1355
Submission Type
Review Panel
CH
Medical Specialty
Clinical Chemistry
Implant
No

Definition

An integrated continuous glucose monitoring system for professional retrospective use is a continuous glucose recording device indicated for the retrospective discovery, analysis, and interpretation of glycemic variability in persons age 2 and older for use by healthcare professionals to guide appropriate patient management. The system is also intended to interface with digitally connected devices.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K182405dexcomDexcom Pro Q Continuous Glucose Monitoring SystemNovember 2, 2018